FDA — authorised 1 March 1956
- Status: approved
🇺🇸 Inversine in United States
FDA authorised Inversine on 1 March 1956
Marketing authorisations
FDA — authorised 1 March 1956
- Application: NDA010251
- Marketing authorisation holder: TARGACEPT
- Local brand name: INVERSINE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 19 March 2013
- Application: ANDA204054
- Marketing authorisation holder: LGM PHARMA
- Status: approved
Inversine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Inversine approved in United States?
Yes. FDA authorised it on 1 March 1956; FDA authorised it on 1 March 1956; FDA authorised it on 19 March 2013.
Who is the marketing authorisation holder for Inversine in United States?
Marketing authorisation holder not available in our data.